Based on final histopathology of all these patients with initial low-risk Luminal A-like cancers, 32 (16%) were unexpectedly upstaged to Luminal B-like and nine (4%) were unexpectedly upstaged to HER2-positive tumors on final histopathology (p < 0.001) (Table 1). Here, ERBB2 is linked to cancer.